BSPS Liquid Based TB Diagnosis

The Frimley Health NHS Foundation Trust is currently in the planning stage of a procurement process titled "BSPS Liquid Based TB Diagnosis." This initiative involves acquiring Mycobacteria Growth Indicator Tube (MGIT) liquid culture system services for diagnosing tuberculosis and other mycobacterial infections. The process is categorised under pathology services and will take place across various regions in the United Kingdom, including UKC, UKD, UKE, and others.

The projected contract period is from 31st March 2026 to 30th March 2031, with a prospective notification for tender to be released by 1st December 2025. This procurement is under a public authority – central government classification, aligned with the legal framework established by UK legislation 2023/54. This tender opens pathways for enterprises specialising in pathology services, specifically those experienced in offering advanced diagnostic systems like the MGIT.

Companies with expertise in healthcare diagnostics, particularly within the realm of infectious disease detection, would find this opportunity particularly lucrative, helping them expand their service offerings in multiple UK regions. Businesses that can provide innovative, reliable, and efficient systems for mycobacterial infection diagnosis will be well-positioned to compete for this strategic contract, fostering substantial growth within the healthcare sector.